Send me a link:

*Text messaging rates may apply.

 Dow Down0.15% Nasdaq Down0.22%

TherapeuticsMD, Inc. (TXMD)

-NYSE MKT
4.68 Up 0.04(0.76%) 10:54AM EDT - Nasdaq Real Time Price
ProfileGet Profile for:
TherapeuticsMD, Inc.
6800 Broken Sound Parkway NW
Third Floor
Boca Raton, FL 33487
United States - Map
Phone: 561-961-1900
Website: http://www.therapeuticsmd.com

Details 
Index Membership:N/A
Sector:Healthcare
Industry:Drug Manufacturers - Major
Full Time Employees:69

Business Summary 

TherapeuticsMD, Inc. operates as a women’s health care product company. The company manufactures and distributes branded and generic prescription prenatal vitamins, as well as over-the-counter vitamins and cosmetics. It offers prenatal vitamins, iron supplements, vitamin D supplements, natural menopause relief products, and cosmetic stretch mark creams under the vitaMedMD brand, as well as duplicate formulations of its prescription prenatal vitamins products under the BocaGreenMD Prena1 name. The company also focuses on conducting the clinical trials for hormone therapy pharmaceutical products that are designed to alleviate the symptoms of and reduce the health risks resulting from menopause-related hormone deficiencies, including hot flashes, osteoporosis, and vaginal dryness. TherapeuticsMD markets its products primarily through a direct national sales force to health care providers, as well as directly through its Website. The company was founded in 2008 and is headquartered in Boca Raton, Florida.

Key Statistics


Company Websites 
Home Page
Search Yahoo! for:
More on TherapeuticsMD, Inc.

Corporate Governance 
TherapeuticsMD, Inc.’s ISS Governance QuickScore as of Jul 1, 2014 is 8. The pillar scores are Audit: 1; Board: 7; Shareholder Rights: 2; Compensation: 10.
Brought to you by Institutional Shareholder Services (ISS)

Key Executives 
 PayExercised
Mr. Robert G. Finizio , 42
Co-Founder, Chief Exec. Officer and Director
616.00K0.00
Mr. John C. K. Milligan IV, 52
Pres, Sec. and Director
493.00K0.00
Mr. Daniel A. Cartwright , 56
Chief Financial Officer, Principal Accounting Officer, VP of Fin. and Treasurer
409.00K0.00
Mr. Mitchell L. Krassan , 48
Chief Strategy Officer and Exec. VP
225.00K0.00
Dr. Brian A. Bernick M.D., 46
Chief Clinical Officer and Director
28.00K0.00
Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in USD.
View Insiders